MSH|^~\&|EPIC|SIISCLIENT818^LINDAS TEST ORGANIZATION|^SIIS||20150202115044||VXU^V04^VXU_V04|225|P|2.5.1||||AL|PID|1||E46700^^^^MR^||DOE^JOHN^C^JR^^^L|SMITH|20140515|M|SMITH^JOHN|2106-3^WHITE^HL70005|115 MAINSTREET^^GOODTOWN^KY^42010^USA^L^010||^PRN^PH^^^270^6009800||EN^ENGLISH^HL70296||||523968712|||2186-5^NOT HISPANIC OR LATINO^HL70012||||||||N|
PD1|||||||||||02^Reminder/recall-any method^HL70215|||||A^Active^HL70441|20150202^20150202 NK1|1|DOE^MARY|MTH^MOTHER^HL70063|
ORC|RE||9645^SIISCLIENT818||||||20150202111146|2001^HARVEY^MARVIN^K|RXA|0|1|20150202|20150202|20^DTaP^CVX^90700^DTAP^CPT|.5|ML^mL^ISO+ ||00^New immunization record^NIP001|JONES^MARK|^^^SIISCLIENT818||||A7894-2|20161115|PMC^SANOFI PASTEUR^MVX||||A RXR|ID^INTRADERMAL^HL70162|LD^LEFT
OBX|1|CE|64994-7^VACCINE FUNDING PROGRAM ELIGIBILITY CATEGORY^LN|1| V02^MEDICAID^HL70064||||||F|||20150202|||VXC40^ELIGIBILITY CAPTURED AT THE IMMUNIZATION LEVEL^CDCPHINVS
OBX|2|CE|30956-7^VACCINE TYPE^LN|2|88^FLU^CVX||||||F|||20150202102525 OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120202||||||F
RXA|0|1|20141215|20141115|141^influenza, SEASONAL 36^CVX^90658^Influenza Split^CPT|999|||01^HISTORICAL INFORMATION â€“ SOURCE UNSPECIFIED^ NIP001||||||||||||A